AU8212591A - Diphenylmethylpiperazine derivative - Google Patents

Diphenylmethylpiperazine derivative

Info

Publication number
AU8212591A
AU8212591A AU82125/91A AU8212591A AU8212591A AU 8212591 A AU8212591 A AU 8212591A AU 82125/91 A AU82125/91 A AU 82125/91A AU 8212591 A AU8212591 A AU 8212591A AU 8212591 A AU8212591 A AU 8212591A
Authority
AU
Australia
Prior art keywords
action
diphenylmethylpiperazine
cardiac muscles
diphenylmethylpiperazine derivative
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82125/91A
Other languages
English (en)
Inventor
Kouji Akimoto
Noboru Kaneko
Tatsuo Nakajima
Tatsushi Oosawa
Hideo Oota
Makoto Takeishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU8212591A publication Critical patent/AU8212591A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU82125/91A 1990-07-10 1991-07-10 Diphenylmethylpiperazine derivative Abandoned AU8212591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2-182095 1990-07-10
JP2182095A JP2651043B2 (ja) 1990-07-10 1990-07-10 ジフェニルメチルピペラジン誘導体

Publications (1)

Publication Number Publication Date
AU8212591A true AU8212591A (en) 1992-02-04

Family

ID=16112265

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82125/91A Abandoned AU8212591A (en) 1990-07-10 1991-07-10 Diphenylmethylpiperazine derivative

Country Status (12)

Country Link
US (1) US5304558A (enExample)
EP (1) EP0541802B1 (enExample)
JP (1) JP2651043B2 (enExample)
CN (1) CN1037840C (enExample)
AT (1) ATE112764T1 (enExample)
AU (1) AU8212591A (enExample)
CA (1) CA2087032C (enExample)
DE (1) DE69104615T2 (enExample)
RU (1) RU2091379C1 (enExample)
TW (1) TW198717B (enExample)
WO (1) WO1992000962A1 (enExample)
ZA (1) ZA915366B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2144669A1 (en) * 1994-03-29 1995-09-30 Kozo Akasaka Biphenyl derivatives
US5658963A (en) * 1995-02-02 1997-08-19 Bisco, Inc. One-component primer/bonding-resin systems
CA2385996C (en) 1999-09-30 2008-02-12 Noboru Kaneko Anticancer agents
AU2001239469A1 (en) * 2000-03-31 2001-10-08 Pfizer Products Inc. Novel piperazine derivatives
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
AU2002326823B2 (en) * 2001-09-06 2005-12-15 Merck Sharp & Dohme Corp. 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
AU2004220548A1 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
JP5318938B2 (ja) 2011-06-09 2013-10-16 株式会社アエタスファルマ ジフェニルメチルピペラジン誘導体、及びそれを用いた医薬組成物
JP6021616B2 (ja) * 2012-12-04 2016-11-09 株式会社アエタスファルマ ３−ピペラジニル−１−ピペリジニル−プロパン誘導体及びそれを含有してなる医薬組成物
KR102257892B1 (ko) 2014-11-26 2021-05-28 삼성전자주식회사 개선된 ｎｆｃ 안테나 및 그 안테나를 갖는 전자 장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR65270B (en) * 1978-10-10 1980-07-31 Fujisawa Pharmaceutical Co Isatin derivatives and processes for the preparation thereof
DE3536797A1 (de) * 1985-10-16 1987-04-16 Studiengesellschaft Kohle Mbh Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung
JPS62192381A (ja) * 1986-02-14 1987-08-22 サンド・アクチエンゲゼルシヤフト プリン誘導体類、その製造方法およびそれらを含有する医薬品
NL8700245A (nl) * 1986-02-14 1987-09-01 Sandoz Ag Purinederivaten, werkwijzen voor hun bereiding en geneesmiddelen die deze derivaten bevatten.
US4885300A (en) * 1988-03-03 1989-12-05 Ortho Pharmaceutical Corporation 4-Substituted pyrazolo[3,4-D]pyrimidine derivatives
US5215987A (en) * 1990-04-23 1993-06-01 Ortho Pharmaceutical Corporation Substituted benzhydryl 2-hydroxypropyl piperazine derivatives

Also Published As

Publication number Publication date
WO1992000962A1 (en) 1992-01-23
US5304558A (en) 1994-04-19
CA2087032A1 (en) 1992-01-11
DE69104615T2 (de) 1995-03-23
ZA915366B (en) 1992-04-29
EP0541802A4 (en) 1993-05-26
JP2651043B2 (ja) 1997-09-10
DE69104615D1 (de) 1994-11-17
ATE112764T1 (de) 1994-10-15
EP0541802B1 (en) 1994-10-12
RU2091379C1 (ru) 1997-09-27
CN1037840C (zh) 1998-03-25
CA2087032C (en) 1999-06-15
TW198717B (enExample) 1993-01-21
JPH0469377A (ja) 1992-03-04
CN1058963A (zh) 1992-02-26
EP0541802A1 (en) 1993-05-19

Similar Documents

Publication Publication Date Title
AU8212591A (en) Diphenylmethylpiperazine derivative
AU616579B2 (en) Substituted thiazoles and their use as fungicides
AU685116B2 (en) Azolylamine derivative
AU5777490A (en) Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
MY102741A (en) Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms
NO940789D0 (no) Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse
CY2124B1 (en) Sulfonamides and derivatives thereof that modulatethe activity of endothelin
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
AU645672B2 (en) Agents for preserving technical materials against insects
AU5595490A (en) Antispasmodic agents
GB9302046D0 (en) Antiumoral compound-v
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
GR3007079T3 (enExample)
HU9203849D0 (en) Thiazole derivatives
FI955829A0 (fi) Heterosyklinen kemia
AU6653190A (en) Fungicides
EP0653207A4 (en) AIDS VIRUS INFECTIVE COMPOSITION.
EP0355409A3 (en) Use of prolylendopeptidase inhibitors in the treatment of aids
UA19166A1 (uk) Гербіцидhа композиція
AU674955B2 (en) Dopamine reincorporation inhibitor
IL102648A0 (en) Pharmaceutical compositions for treating diabetes,comprising 1,4-dihydropyridines
ES2115178T3 (es) Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica.
AU1121892A (en) Isoquinoline derivatives
ATE154243T1 (de) Hemmstoff der blutgefässhypertrophie